Results 111 to 120 of about 48,863 (239)

Population Pharmacokinetics to Support Intravenous and Enteral Methadone Dosing in Children

The Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.
Abstract Methadone is used in hospitalized children to treat pain and iatrogenic opiate withdrawal. Optimal pediatric dosing for both enteral and intravenous methadone is unknown. We conducted two prospective, multi‐center, open‐label studies to characterize the pharmacokinetics of methadone in the pediatric population.
Kevin M. Watt, Elizabeth J. Thompson, Lisa Lam, Kanecia Zimmerman, Christoph P. Hornik, Andrew M. Atz, Allison Fernandez, Susan R. Hupp, Varsha Bhatt‐Mehta, Daniel K. Benjamin Jr, Ravinder Anand, Michael Cohen‐Wolkowiez, Daniel Gonzalez, P. Brian Smith, Edmund V. Capparelli, the Best Pharmaceuticals for Children Act — Pediatric Trials Network Steering Committee   +15 more
wiley   +1 more source

Itraconazole

Reactions weekly, 2020

semanticscholar   +1 more source

A Rational Approach to Pharmacotherapy in Pregnancy

The Journal of Clinical Pharmacology, Volume 66, Issue 1, January 2026.
Abstract Most pregnant individuals are exposed to at least one medication, whether prescription or over the counter, during pregnancy. Despite the ubiquity of medication use in pregnancy, there remains no standardized framework to guide clinicians in selecting the most appropriate pharmacotherapy that balances maternal needs with fetal safety. This gap
Gregory W. Kirschen, Kevin Watt, Ahizechukwu C. Eke   +2 more
wiley   +1 more source

Research priorities for advanced HIV disease in Latin America and the Caribbean region: a modified Delphi study

Journal of the International AIDS Society, Volume 29, Issue 1, January 2026.
Abstract Introduction Advanced HIV disease (AHD) remains a leading cause of mortality in Latin America and the Caribbean (LAC), driven by late diagnosis, treatment gaps and structural barriers, particularly among key populations and children. Persistent disparities in healthcare access, stigma, and limited health system capacity highlight the need for ...
Evelina Chapman, Omar Sued, Jorge O. Maia Barreto, Claudia P. Cortes, Brenda Crabtree Ramírez, José E. Vidal, Antonio Camiro‐Zúñiga, Freddy Perez   +7 more
wiley   +1 more source

ITRACONAZOLE: A PROMISING REPURPOSED CHEMOTHERAPEUTIC AGENT FOR TONGUE CARCINOMA

, 2023
Hala El-kammar, Mohamed Ammar, Iten M. Fawzy, Dina Kashkoush, Nermeen Afifi   +4 more
openalex   +1 more source

Itraconazole versus potassium iodide for cutaneous sporotrichosis: weighing up the pros and cons [PDF]

, 2021
Hudson Dutra Rezende, Ana Carolina Trombetta Madia, Andressa de Deus Mateus, Eneas Van Der Maas do Bem Filho, João Vitor Corte Perez, Pedro Augusto Corrêa de Araújo Rodrigues Caldas, Sandra Lopes Mattos e Dinato   +6 more
openalex   +1 more source

Drugs in focus: Budesonide and its role in paediatric gastrointestinal disorders

Journal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 1, Page 60-69, January 2026.
Abstract Budesonide is a glucocorticoid with strong topical anti‐inflammatory properties and minimal systemic effects due to extensive first‐pass hepatic metabolism. It is designed for targeted delivery within the gastrointestinal (GI) tract and is available in oral and rectal formulations.
Sohail Aziz, Maria Giovanna Puoti, Amit Assa, Zrinjka Misak, Emmanuel Mas, Osvaldo Borrelli, Jernej Dolinšek, Javier Martin‐de‐Carpi, Isabelle Scheers, Christos Tzivinikos, Matjaž Homan, Caterina Strisciuglio   +11 more
wiley   +1 more source

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.

New England Journal of Medicine, 2007
O. Cornely, J. Maertens, D. Winston, J. Perfect, A. Ullmann, T. Walsh, D. Helfgott, J. Hołowiecki, D. Stockelberg, Y. Goh, M. Petrini, C. Hardalo, R. Suresh, D. Angulo-Gonzalez   +13 more
semanticscholar   +1 more source

Nanotechnology in Skin Cancer Therapy: Recent Progress in Targeted Delivery

The Kaohsiung Journal of Medical Sciences, Volume 42, Issue 1, January 2026.
ABSTRACT Skin cancer, encompassing melanoma and non‐melanoma types, remains a significant public health concern globally. Conventional therapies—such as surgery, radiotherapy, chemotherapy, and immunotherapy—are constrained by poor skin penetration, systemic toxicity, and high recurrence rates.
Huang‐Ping Yu, Ching‐Yun Hsu, Jia‐You Fang, Zih‐Chan Lin   +3 more
wiley   +1 more source

Treatment of severe chromoblastomycosis with itraconazole and 5-flucytosine association [PDF]

, 2010
Vicente Sperb Antonello, Marcelo Campos Appel da Silva, Eduardo Cambruzzi, Dimas Alexandre Kliemann, Breno Santos, Flávio Queiroz‐Telles   +5 more
openalex   +1 more source